Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-26-008880·Akari Therapeutics Plc
Schedule 13D ownership disclosure
AKARI THERAPEUTICS PLC
Ordinary Shares, $0.000000005 par value · CUSIP: 00972G207
Event date: 2026-03-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ray Prudo, M.D.Reported CIK 0001653262
Shares: 8,391,326,467.00 · Class: 8.9%
- RPC Pharma Limited
Shares: 800,766,600.00 · Class: 0.87%
- Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company
Shares: 38,709,600.00 · Class: 0.042%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-008880
- Form type
- SCHEDULE 13D/A
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Mar 04, 2026
- Reporting period
- Mar 02, 2026
- Description
- Schedule 13D beneficial ownership